Adjuvant Platform Head - Vaccines

Adjuvant Platform Head - Vaccines

Sanofi has developed a number of diverse Adjuvant formulations internally and has access to others via external partnerships and collaborations. The Adjuvant technology is a critical component of successful vaccines based on recombinant protein technology and is likely to be a key success factor for such vaccines in the more scientifically challenging fields of the future, including therapeutic immunotherapies. Furthermore, we are evaluating the role of Adjuvants in potentiating responses to mRNA vaccines and polysaccharide conjugate technologies.

A strong matrix leader is required to lead a cross-functional Adjuvant Platform team with the mission to ensure a cohesive strategy, plan and execution in the Adjuvant technology arena, including the ability to oversee clinical evaluations of Adjuvant formulations and the ability to secure external funding to advance our progress in developing and validating Adjuvants to support our current and future Vaccines portfolio.

We are an innovative global healthcare company that helps the world stay ahead of infectious diseases by delivering more than 500 million vaccine doses a year. Across different countries, our talented teams are exploring new technologies to protect people and promote healthy communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main Responsibilities

Lead the cross-functional Adjuvant Platform Global Team to deliver the strategy, plans and execution of Sanofi's Adjuvant technology platform, aligned with the current and future Vaccine Project needs.

• Defends the Platform strategy at governance boards, including scientific review as well as investment decisions
• Manages multiple internal and external stakeholders, including at Executive levels
• Provides input into team member performance reviews
• Fosters and implements internal (across Sanofi therapeutic areas) or external innovation solutions for the development of an Adjuvant platform for infectious disease targets
• Close collaboration with Global Project Heads (GPHs), Global Clinical and Development Supply (GCDS), Manufacturing and Supply (M&S), Innovation and Ext R&D, Antigen Design, Global Immunology Functions and the mRNA Center of Excellence
• Stays informed on the state-of-the-art approaches for Adjuvants, characterization and immunological assessment, through efficient internal connections, and competitive pipeline assessments
• Secures IP strategy ensuring Freedom to Operate and integrated scientific communication
• Accountable for developing both integrated strategy & development plan and its effective execution through the platform team, in compliance with approved timelines & budget
• Accountable for building and maintaining aligned strategy with external partners (if any)
• Ensures that the right interactions with regulatory authorities are in place
• Ensures that risk-mitigation plan is articulated, escalated, validated by relevant internal governance bodies and monitored
• Resolves resource & budget issues with functions or decision bodies in order to meet platform plan objective
• Additionally, acts as GPH to lead one or more new target Task Force pre-M0 evaluations and / or external opportunity assessments and due diligences

About You

Required Qualifications

Preferred Qualifications

Skills & Competencies

Why Choose Us?

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.